IL2 and systemic lupus erythematosus: Low-dose IL-2 therapy has been used in the clinical treatment of autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and T1D and achieved excellent effects (100, 102–104).